Monograph Details
|
|
Immune System
> Immunomodulators
|
|
COPAXONE |
| Manufacturer |
|
Teva Neuroscience |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Immunomodulator. |
| Generic Name |
|
Glatiramer acetate 20mg/mL; soln for SC inj; contains mannitol; preservative-free. |
| Indications |
|
To reduce the frequency of relapses in relapsing-remitting multiple sclerosis. |
| Children |
|
<18 years: not recommended. |
| Adults |
|
Supervise first dose. ≥18 years: 20mg SC daily. |
| Precautions |
|
Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
Inj site and post-inj reactions, vasodilatation, chest pain, asthenia, infection, pain, nausea, arthralgia, anxiety, hypertonia. |
| How Supplied |
|
Single-use prefilled syringes—30 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
